Browsing: Breast

Top Line: What are the long term outcomes of ultrahypofractionated whole breast radiation?The Study: FAST-Forward was the landmark phase 3…

The Headline:With longer follow-up SERENA-6 continues to break ground in the frontier of circulating tumor (ct)DNA-guided early systemic therapy changes.…

AXSANA is a behemoth international prospective observational study analyzing outcomes after different axillary procedures for clinically node-positive breast cancer following…

The Headline: Genomic-guided chemotherapy omission is expanding in clinically high-risk ER+/HER2− breast cancer. The Study: The phase 3 OPTIMA trial…

Can low risk, early stage breast cancer be treated with ablative radiation alone? In this phase 2 trial, 20 patients…

Top Line: A combined look at trials assessing radiation omission for good-risk ductal carcinoma in situ (DCIS) sharpens the radiation…

Observational electronic medical record data on >840K women with breast cancer indicates use of a GLP-1 agonist is associated with…

A retrospective look at node-negative, hormone receptor-positive HER2-negative breast cancers ≤1 cm treated with breast conservation between 2008-2020 at MSKCC…

Top Line: Is it safe to use a simultaneous or concurrent boost for whole breast radiation?The Study: Giving a boost…

Top Line: The indications for axillary dissection for breast cancer when radiation is planned are diminishingly small.The Study: This US…